12 titres de soins de sant en mouvement lors de la session du 09/04/2024Benzinga • 17 days ago
Gagnants
L'action Acrivon Therapeutics (NASDAQ:ACRV) a grimp mardi de 73,43% 10,25 dollars lors de la session ordinaire.
L'action BioSig Technologies (NASDAQ:BSGM) a augment de 24,20% 1,54...
Share to Feed
Acrivon Therapeutics has entered into a securities purchase agreement to issue and sell 8.235 million shares of its common stock at a price of $8.50 per share, as well as pre-funded warrants to...
Gagnants
Le titre Acrivon Therapeutics (NASDAQ:ACRV) a mont mardi de 75,12% 10,35 dollars lors de la session pre-market.
Le titre Biophytis (NASDAQ:BPTS) a augment de 40,48% 0,45 dollars.
Le...
Acrivon Therapeutics (NASDAQ:ACRV - Get Free Report)s stock had its "outperform" rating restated by stock analysts at BMO Capital Markets in a research report issued on Monday, Benzinga...
Silvan Tuerkcan, an analyst from JMP Securities, maintained the Buy rating on Acrivon Therapeutics, Inc. (ACRV Research Report). The associated p...
Acrivon Therapeutics, Inc. (NASDAQ:ACRV - Get Free Report) saw a large growth in short interest in the month of March. As of March 15th, there was short interest totalling 484,000 shares, a growth...
HC Wainwright reissued their buy rating on shares of Acrivon Therapeutics (NASDAQ:ACRV - Free Report) in a research report report published on Thursday, Benzinga reports. HC Wainwright currently has...
Comparing ACRV's Performance to Analyst Projections and Unveiling Key FinancialsRelated Stocks: ACRV...
Acrivon Therapeutics (NASDAQ:ACRV - Get Free Report)s stock had its "buy" rating reissued by equities research analysts at HC Wainwright in a research report issued on Thursday, Benzinga...
Acrivon Therapeutics, Inc. (NASDAQ:ACRV Free Report) Analysts at HC Wainwright issued their Q1 2024 EPS estimates for shares of Acrivon Therapeutics in a research report issued on...